Clinical Trial Update: Evaluation of Daclatasvir (DCV) in Combination With Sofosbuvir (SOF) in Children With Chronic Hepatitis C (CHC) Infection [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating daclatasvir plus sofosbuvir in children with chronic hepatitis C was terminated; results were posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Daclatasvir (daclatasvir)
• Sofosbuvir (sofosbuvir)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Hepatitis C, Chronic Hepatitis | Phase 2 | Status: TERMINATED | Results posted: 2021-04-20